Cargando…
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
Glioblastoma (GBM) is a lethal primary malignant brain tumor with no current effective treatments. The recent emergence of immuno-virotherapy and FDA approval of T-VEC have generated a great expectation towards oncolytic herpes simplex viruses (oHSVs) as a promising treatment option for GBM. Since t...
Autores principales: | Nguyen, Hong-My, Saha, Dipongkor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917312/ https://www.ncbi.nlm.nih.gov/pubmed/33659221 http://dx.doi.org/10.2147/OV.S268426 |
Ejemplares similares
-
Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis
por: Ghouse, Shanawaz M., et al.
Publicado: (2020) -
Multi-parametric flow cytometry staining procedure for analyzing tumor-infiltrating immune cells following oncolytic herpes simplex virus immunotherapy in intracranial glioblastoma
por: Bommareddy, Praveen K., et al.
Publicado: (2019) -
Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy
por: Nguyen, Hong-My, et al.
Publicado: (2020) -
Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016) -
Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018)